title: New drugs: dulaglutide, olodaterol hydrochloride, and vorapaxar sulfate.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Dean R
authors.initials: DR
authors.lastname: Wetty
mesh_terms: D058665:Adrenergic beta-1 Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D048588:Benzoxazines / Q000009:adverse effects / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004763:Glucagon-Like Peptides / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007141:Immunoglobulin Fc Fragments / Q000009:adverse effects / Q000627:therapeutic use*; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D058665:Adrenergic beta-1 Receptor Agonists; D048588:Benzoxazines; D001993:Bronchodilator Agents; D007004:Hypoglycemic Agents; D007141:Immunoglobulin Fc Fragments; D007783:Lactones; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; D011993:Recombinant Fusion Proteins; D004763:Glucagon-Like Peptides; C549647:olodaterol; C555680:dulaglutide; C530299:vorapaxar